CVS Health Corporation Q3 2025 Earnings Recap

CVS Health reported strong third-quarter results with adjusted earnings per share rising to $1.60, prompting an increase in full-year guidance. The diversified business strategy shows promise, despite challenges in Health Care Delivery.

Key Takeaways

• Adjusted operating income reached $3.5 billion, reflecting robust performance across the enterprise.
• Full-year adjusted earnings per share guidance revised upwards to $6.55–$6.65 from the previous range of $6.30–$6.40.
• Aetna continues to excel, leading in Medicare Advantage Stars Ratings with over 81% of members in 4-star plans or higher.
• A $5.7 billion goodwill impairment was recorded due to restrained growth expectations for Oak Street Health, underscoring the need for strategic adjustments.
• While navigating challenges in Pharmacy Services, CVS remains committed to drug cost transparency and innovative pricing models for consumers.